Regular ArticleEndothelin and Free Radicals Modulate Microvascular Responses in Streptozotocin-Induced Diabetic Rats
References (37)
- et al.
Mechanism of hydroxyl radical-induced modulation of vascular tone
Free Rad. Biol. Med.
(1997) - et al.
Reduced neurogenic inflammation in streptozotocin-diabetic rats due to microvascular changes but not to substance P depletion
Eur. J. Pharmacol.
(1985) - et al.
Effects of glucose and insulin on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells
Metabolism
(1991) - et al.
Functional changes in vascular smooth muscle and endothelium of arteries during diabetes mellitus
Life Sci.
(1992) - et al.
Sequence of events in substance P-mediated plasma extravasation in rat skin
Brain Res.
(1989) - et al.
Free radicals contribute to the reduction in peripheral vascular responses and the maintenance of thermal hyperalgesia in rats with chronic construction injury
Pain
(1999) - et al.
Mechanisms underlying the vascular activity β-amyloid protein fragment (βA4 25-35) at level of skin microvasculature
Brain Res.
(1996) - et al.
Experimental diabetes upregulates the expression of uretereral endothelin receptors
Peptides
(1997) - et al.
Hydroxyl radical formation in diabetic rats induced by streptozotocin
Life Sci.
(1995) - et al.
Streptozotocin-induced diabetes is associated with altered expression of peptide-encoding mRNAs in rat sensory neurons
Peptides
(1996)
Cardiac and renal endothelin-1 binding sites in streptozotocin-induced diabetic rats
Pharmacol. Res.
NK1 receptor mediation of neurogenic plasma extravasation in rat skin
Br. J. Pharmacol.
The density and distribution of endotehlin-1 and endothelin receptor subtypes in normal and diabetic rat corpus cavenosum
Br. J. Urol.
Neurogenic cutaneous vasodilatation and plasma extravasation in diabetic rats: Effect of insulin and nerve growth factor
Br. J. Pharmacol.
Endothelial dysfunction in mesenteric arteries of diabetic rats: Role of free radicals
Am. J. Physiol.
Characterization of 125l-endothelin-1 binding to rat and rabbit renal microvasculature
J. Pharmacol. Exp. Ther.
Impaired connective tissue repair in streptozotocin-induced diabetes shows ultrastructural signs of impaired contraction
J. Surg. Res.
oxidative stress and diabetic vascular complications
Diabetes Care
Cited by (22)
Short- and long-term modulation of microvascular responses in streptozotocin-induced diabetic rats by glycosylated products
2010, Journal of Diabetes and its ComplicationsCitation Excerpt :However, occasionally, some rats lost close to 15% of their body mass due to the severity of diabetes, and these (n=1–2) rats were given insulin treatment (2 IU/100 g, sc, once or twice only) to give them respite from the catabolic dominance of diabetes while allowing regular and severe hyperglycemia. We previously showed a significant reduction in average weight gain, BBF, and responses to SP and SNP in diabetic rats over the experimental period (4 weeks) (Bassirat & Khalil, 2000). The average weight gain in normal rats was 30.1 g/week compared to only 8.8 g/week in diabetic rats during this period (data not shown).
Influence of Helicteres isora administration for diabetes mellitus: The effect on changes in tissue fatty acid composition
2009, Food and Chemical ToxicologyEffect of an 8-week resistance training program on cutaneous perfusion in type 2 diabetes
2006, Microvascular ResearchThe effect of N-acetylcysteine on cardiac contractility to dobutamine in rats with streptozotocin-induced diabetes
2005, European Journal of PharmacologyCitation Excerpt :Chronic treatment of alloxan-induced diabetic mice with N-acetylcysteine reduced the activation of the nuclear transcription factor-κB in the pancreas, and this has the potential of reducing the production of proinflammatory cytokines such as interleukins and inducible nitric oxide synthase (Ho et al., 1999). Acute administration of N-acetylcysteine also improved vasodilatation response to electrical stimulation or to substance P in rats with streptozotocin-induced diabetes (Bassirat and Khalil, 2000). Chronic treatment with N-acetylcysteine prevented the development of peripheral neuropathy in streptozotocin-induced diabetic rats (Sagara et al., 1996), as well as ultrastructure changes in the erythrocytes of patients with type II diabetes (Straface et al., 2002).
Change in cutaneous perfusion following 10 weeks of aerobic training in Type 2 diabetes
2005, Journal of Diabetes and its Complications